About Dr. Zhou
Yubin Zhou, MB, PhD, is an associate professor Texas A&M Institute of Biosciences and Technology. His research interests focus on elucidating the role of calcium signaling and epigenetic modifications in health and disease, and developing novel anti-cancer therapeutics and optogenetic platforms for disease intervention.
Dr. Zhou serves as an associate editor for Current Molecular Medicine and sits in the editorial board of Molecular and Cellular Biology and Scientific Reports. He holds three patents and has published over 70 peer-reviewed journal articles, reviews and book chapters. Zhou's recent work in calcium channels, phospholipid metabolism, optogenetics and immunoengineering was highlighted by Nature Cell Biology, Nature Structural and Molecular Biology, Trends in Biotechnology, National Institute of General Medical Sciences and was featured in multiple media outlets. His ongoing research is supported by multiple grants from the National Institutes of Health, Cancer Prevention & Research Institute of Texas, the Welch Foundation and the American Cancer Society.
Dr. Zhou received his Bachelor of Medicine from Zhejiang University and Master of Science in chemistry and in 2008, doctorate in biochemistry from Georgia State University.
Dr. Zhou was the recipient of the Leukemia & Lymphoma Society Fellow Award and Special Fellow Award, the American Cancer Society Research Scholar Award, and the Texas A&M College of Medicine Research Excellence Award.
Vital Record news coverage
Texas A&M faculty awarded more than $8.6 million from CPRIT
Six recently-funded research projects at Texas A&M look to reduce the burden of cancer in Texas
August 22, 2017
Building bridges within the cell—using light
How a new technique allows researchers to tune communication between organelles on the scale of nanometers
July 26, 2017
Epigenetic changes on demand: Turning the ‘traffic lights’ of DNA from red to green
Texas A&M researchers devise tool to decipher the epigenetic codes of the human genome
April 20, 2017